相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model
Monique M. A. de Almeida et al.
STEM CELL REPORTS (2023)
Influence of SARS-CoV-2 on Adult Human Neurogenesis
Tomasz Stepien et al.
CELLS (2023)
Nesfatin-1 ameliorates oxidative brain damage and memory impairment in rats induced with a single acute epileptic seizure
Sevil Arabaci Tamer et al.
LIFE SCIENCES (2022)
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren-Jun Hsu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Comprehensive Clinical Characterisation of Brain Fog in Adults Reporting Long COVID Symptoms
Glenn Jennings et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Development, analysis, and preclinical evaluation of inactivated vaccine candidate for prevention of Covid-19 disease
Engin Alp Onen et al.
ALL LIFE (2022)
Glutathione, polyamine, and lysophosphatidylcholine synthesis pathways are associated with circulating pro-inflammatory cytokines
Ming Liu et al.
METABOLOMICS (2022)
Interactions of SARS-CoV-2 with the Blood-Brain Barrier
Michelle A. Erickson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
How COVID-19 Affects the Brain
Maura Boldrini et al.
JAMA PSYCHIATRY (2021)
SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19
Aniello Maiese et al.
BRAIN PATHOLOGY (2021)
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2021)
Neuropathological analysis of the brains of fifty-two patients with COVID-19
Teresa Wierzba-Bobrowicz et al.
FOLIA NEUROPATHOLOGICA (2021)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
The cognitive consequences of the COVID-19 epidemic: collateral damage?
Karen Ritchie et al.
BRAIN COMMUNICATIONS (2020)
5234KAND567, the first selective small molecule CX3CR1 antagonist in clinical development, mediates anti-inflammatory cardioprotective effects in rodent models of atherosclerosis and myocardial infarction
S Abdelmoaty et al.
EUROPEAN HEART JOURNAL (2019)
Oestrogen receptor ERα and ERβ agonists ameliorate oxidative brain injury and improve memory dysfunction in rats with an epileptic seizure
Tuerkan Koyuncuoglu et al.
EXPERIMENTAL PHYSIOLOGY (2019)
AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor
Linda Cederblad et al.
BIOCHEMICAL JOURNAL (2016)
The CA3 region of the hippocampus: how is it? What is it for? How does it do it?
Enrico Cherubini et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis
Anna Ridderstad Wollberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity
Graham K. Sheridan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Loss of Angiotensin-Converting Enzyme 2 Exacerbates Myocardial Injury via Activation of the CTGF-Fractalkine Signaling Pathway
Bei Song et al.
CIRCULATION JOURNAL (2013)
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX(3)CR1)
Sofia Karlstrom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Object recognition test in mice
Marianne Leger et al.
NATURE PROTOCOLS (2013)
Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency
Jiang Wu et al.
NEUROBIOLOGY OF AGING (2013)
Antidepressants recruit new neurons to improve stress response regulation
A. Surget et al.
MOLECULAR PSYCHIATRY (2011)
NCS-1 in the Dentate Gyrus Promotes Exploration, Synaptic Plasticity, and Rapid Acquisition of Spatial Memory
Bechara J. Saab et al.
NEURON (2009)
Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
M Dib et al.
JOURNAL OF NEUROLOGY (2002)